Pacific Biosciences Of California (PACB) Goodwill & Intangibles (2021 - 2026)

Pacific Biosciences Of California's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $331.9 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 1.21% year-over-year to $331.9 million in Q1 2026; TTM through Mar 2026 was $331.9 million, a 1.21% decrease from a year earlier, with the FY2025 full-year figure at $332.9 million, down 52.94% from the prior year.
• Goodwill & Intangibles steadied at $331.9 million in Q1 2026 per PACB's latest filing, from $332.9 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $925.7 million in Q3 2023 and bottomed at $331.9 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $812.3 million (2024), against an average of $662.6 million.
• Across the five-year window, Goodwill & Intangibles surged 109.97% in 2022 and plunged 63.18% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $820.2 million in 2022, then tumbled by 37.91% to $509.3 million in 2023, then surged by 38.89% to $707.3 million in 2024, then sank by 52.94% to $332.9 million in 2025, then fell by 0.31% to $331.9 million in 2026.
• Per Business Quant, the three latest PACB Goodwill & Intangibles figures stand at $331.9 million (Q1 2026), $332.9 million (Q4 2025), and $333.9 million (Q3 2025).